LivaNova (LIVN) Cash & Equivalents Growth (3y) (2018 - 2026)
LivaNova (LIVN) Cash & Equivalents Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 32.23% |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 18.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.38% |
| Mar 31, 2026 | 20.48% |
| Dec 31, 2025 | 28.23% |
| Mar 31, 2025 | 33.04% |
| Sep 30, 2024 | 23.96% |
| Jun 30, 2024 | -2.65% |
| Mar 31, 2024 | 6.67% |
| Dec 31, 2023 | 7.19% |
| Sep 30, 2023 | 9.46% |
| Jun 30, 2023 | 10.22% |
| Mar 31, 2023 | 34.86% |
| Dec 31, 2022 | 70.20% |
| Sep 30, 2022 | 54.03% |
| Jun 30, 2022 | 88.42% |
| Mar 31, 2022 | 83.47% |
| Sep 30, 2021 | 31.51% |
| Jun 30, 2021 | 90.85% |
| Mar 31, 2021 | 57.24% |
| Dec 31, 2020 | 39.26% |
| Sep 30, 2020 | 51.78% |